nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Topoisomerase Inhibitors—Etoposide—brain cancer	0.488	1	CiPCiCtD
Epirubicin—bone cancer—brain cancer	0.193	0.577	CtDrD
Epirubicin—peripheral nervous system neoplasm—brain cancer	0.141	0.423	CtDrD
Epirubicin—TOP2A—Etoposide—brain cancer	0.0377	0.643	CbGbCtD
Epirubicin—ABCC1—Etoposide—brain cancer	0.0209	0.357	CbGbCtD
Epirubicin—CHD1—hindbrain—brain cancer	0.00157	0.0725	CbGeAlD
Epirubicin—CHD1—brainstem—brain cancer	0.000899	0.0415	CbGeAlD
Epirubicin—Idarubicin—CYP2C9—brain cancer	0.000818	1	CrCbGaD
Epirubicin—CHD1—telencephalon—brain cancer	0.000797	0.0369	CbGeAlD
Epirubicin—CHD1—gonad—brain cancer	0.000666	0.0308	CbGeAlD
Epirubicin—CHD1—pituitary gland—brain cancer	0.000649	0.03	CbGeAlD
Epirubicin—CHD1—medulla oblongata—brain cancer	0.000627	0.029	CbGeAlD
Epirubicin—AURKA—Teniposide—Etoposide—brain cancer	0.000604	0.567	CbGdCrCtD
Epirubicin—CHD1—midbrain—brain cancer	0.000573	0.0265	CbGeAlD
Epirubicin—CHD1—spinal cord—brain cancer	0.000559	0.0258	CbGeAlD
Epirubicin—DHCR7—telencephalon—brain cancer	0.000538	0.0249	CbGeAlD
Epirubicin—AURKA—gonad—brain cancer	0.000536	0.0248	CbGeAlD
Epirubicin—AURKA—pituitary gland—brain cancer	0.000523	0.0242	CbGeAlD
Epirubicin—CHD1—endocrine gland—brain cancer	0.000503	0.0233	CbGeAlD
Epirubicin—CHD1—head—brain cancer	0.000497	0.023	CbGeAlD
Epirubicin—YWHAG—telencephalon—brain cancer	0.000493	0.0228	CbGeAlD
Epirubicin—CHD1—central nervous system—brain cancer	0.000453	0.021	CbGeAlD
Epirubicin—DHCR7—gonad—brain cancer	0.000449	0.0208	CbGeAlD
Epirubicin—CHD1—cerebellum—brain cancer	0.000443	0.0205	CbGeAlD
Epirubicin—DHCR7—pituitary gland—brain cancer	0.000438	0.0202	CbGeAlD
Epirubicin—DHCR7—medulla oblongata—brain cancer	0.000422	0.0195	CbGeAlD
Epirubicin—YWHAG—gonad—brain cancer	0.000412	0.019	CbGeAlD
Epirubicin—AURKA—endocrine gland—brain cancer	0.000405	0.0187	CbGeAlD
Epirubicin—YWHAG—pituitary gland—brain cancer	0.000402	0.0186	CbGeAlD
Epirubicin—AURKA—head—brain cancer	0.0004	0.0185	CbGeAlD
Epirubicin—YWHAG—medulla oblongata—brain cancer	0.000388	0.0179	CbGeAlD
Epirubicin—DHCR7—midbrain—brain cancer	0.000386	0.0179	CbGeAlD
Epirubicin—DHCR7—spinal cord—brain cancer	0.000377	0.0174	CbGeAlD
Epirubicin—AURKA—central nervous system—brain cancer	0.000365	0.0169	CbGeAlD
Epirubicin—CHD1—brain—brain cancer	0.00036	0.0166	CbGeAlD
Epirubicin—YWHAG—midbrain—brain cancer	0.000354	0.0164	CbGeAlD
Epirubicin—YWHAG—spinal cord—brain cancer	0.000346	0.016	CbGeAlD
Epirubicin—DHCR7—endocrine gland—brain cancer	0.000339	0.0157	CbGeAlD
Epirubicin—DHCR7—head—brain cancer	0.000335	0.0155	CbGeAlD
Epirubicin—YWHAG—endocrine gland—brain cancer	0.000311	0.0144	CbGeAlD
Epirubicin—YWHAG—head—brain cancer	0.000307	0.0142	CbGeAlD
Epirubicin—DHCR7—central nervous system—brain cancer	0.000306	0.0141	CbGeAlD
Epirubicin—PLA2G4A—pituitary gland—brain cancer	0.0003	0.0139	CbGeAlD
Epirubicin—DHCR7—cerebellum—brain cancer	0.000299	0.0138	CbGeAlD
Epirubicin—AURKA—brain—brain cancer	0.00029	0.0134	CbGeAlD
Epirubicin—PLA2G4A—medulla oblongata—brain cancer	0.000289	0.0134	CbGeAlD
Epirubicin—UGT2B7—endocrine gland—brain cancer	0.000281	0.013	CbGeAlD
Epirubicin—YWHAG—central nervous system—brain cancer	0.00028	0.013	CbGeAlD
Epirubicin—YWHAG—cerebellum—brain cancer	0.000274	0.0127	CbGeAlD
Epirubicin—PLA2G4A—midbrain—brain cancer	0.000264	0.0122	CbGeAlD
Epirubicin—PLA2G4A—spinal cord—brain cancer	0.000258	0.0119	CbGeAlD
Epirubicin—DHCR7—brain—brain cancer	0.000243	0.0112	CbGeAlD
Epirubicin—PLA2G4A—endocrine gland—brain cancer	0.000232	0.0107	CbGeAlD
Epirubicin—TOP2A—Teniposide—Etoposide—brain cancer	0.000231	0.217	CbGdCrCtD
Epirubicin—TOP2A—Podofilox—Etoposide—brain cancer	0.000231	0.217	CbGdCrCtD
Epirubicin—YWHAG—brain—brain cancer	0.000223	0.0103	CbGeAlD
Epirubicin—ABCC1—telencephalon—brain cancer	0.000211	0.00973	CbGeAlD
Epirubicin—PLA2G4A—central nervous system—brain cancer	0.000209	0.00967	CbGeAlD
Epirubicin—ABCC1—pituitary gland—brain cancer	0.000171	0.00793	CbGeAlD
Epirubicin—PLA2G4A—brain—brain cancer	0.000166	0.00768	CbGeAlD
Epirubicin—ABCC1—cerebellum—brain cancer	0.000117	0.00541	CbGeAlD
Epirubicin—ABCC1—brain—brain cancer	9.5e-05	0.00439	CbGeAlD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	7.8e-05	0.00321	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	7.8e-05	0.00321	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—HES1—brain cancer	7.71e-05	0.00317	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	7.46e-05	0.00307	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.38e-05	0.00304	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—brain cancer	7.21e-05	0.00297	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.99e-05	0.00288	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PIK3CG—brain cancer	6.79e-05	0.0028	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	6.74e-05	0.00278	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PPP1R12A—brain cancer	6.67e-05	0.00274	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	6.66e-05	0.00274	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	6.59e-05	0.00271	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	6.55e-05	0.0027	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—brain cancer	6.49e-05	0.00267	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—MYC—brain cancer	6.42e-05	0.00264	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	6.39e-05	0.00263	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—SKP2—brain cancer	6.39e-05	0.00263	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MPL—brain cancer	6.38e-05	0.00263	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	6.2e-05	0.00255	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—STAT3—brain cancer	6.19e-05	0.00255	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—S100A10—brain cancer	6.12e-05	0.00252	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP2C9—brain cancer	6.07e-05	0.0025	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.06e-05	0.00249	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.9e-05	0.00243	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—APC—brain cancer	5.72e-05	0.00235	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—SKP2—brain cancer	5.71e-05	0.00235	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	5.71e-05	0.00235	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK6—brain cancer	5.69e-05	0.00234	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	5.65e-05	0.00233	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	5.49e-05	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—brain cancer	5.48e-05	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—RELA—brain cancer	5.36e-05	0.00221	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	5.34e-05	0.0022	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.29e-05	0.00218	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.23e-05	0.00215	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—BSG—brain cancer	5.16e-05	0.00213	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	5.15e-05	0.00212	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.11e-05	0.00211	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDK6—brain cancer	5.09e-05	0.0021	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—OR4C12—brain cancer	5.07e-05	0.00209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—OR14C36—brain cancer	5.07e-05	0.00209	CbGpPWpGaD
Epirubicin—Anaemia—Hydroxyurea—brain cancer	4.98e-05	0.000698	CcSEcCtD
Epirubicin—Hypoaesthesia—Carmustine—brain cancer	4.97e-05	0.000698	CcSEcCtD
Epirubicin—Decreased appetite—Procarbazine—brain cancer	4.94e-05	0.000692	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Etoposide—brain cancer	4.93e-05	0.000691	CcSEcCtD
Epirubicin—Oedema peripheral—Carmustine—brain cancer	4.93e-05	0.000691	CcSEcCtD
Epirubicin—Connective tissue disorder—Carmustine—brain cancer	4.91e-05	0.000689	CcSEcCtD
Epirubicin—Fatigue—Procarbazine—brain cancer	4.89e-05	0.000686	CcSEcCtD
Epirubicin—Haemoglobin—Temozolomide—brain cancer	4.86e-05	0.000681	CcSEcCtD
Epirubicin—Malaise—Hydroxyurea—brain cancer	4.85e-05	0.000681	CcSEcCtD
Epirubicin—Pain—Procarbazine—brain cancer	4.85e-05	0.000681	CcSEcCtD
Epirubicin—Constipation—Procarbazine—brain cancer	4.85e-05	0.000681	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.85e-05	0.002	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—SKP2—brain cancer	4.84e-05	0.00199	CbGpPWpGaD
Epirubicin—Hepatitis—Temozolomide—brain cancer	4.83e-05	0.000678	CcSEcCtD
Epirubicin—Haemorrhage—Temozolomide—brain cancer	4.83e-05	0.000678	CcSEcCtD
Epirubicin—Dysphagia—Etoposide—brain cancer	4.83e-05	0.000677	CcSEcCtD
Epirubicin—Leukopenia—Hydroxyurea—brain cancer	4.82e-05	0.000676	CcSEcCtD
Epirubicin—Visual impairment—Carmustine—brain cancer	4.82e-05	0.000676	CcSEcCtD
Epirubicin—Hypoaesthesia—Temozolomide—brain cancer	4.81e-05	0.000674	CcSEcCtD
Epirubicin—Pharyngitis—Temozolomide—brain cancer	4.8e-05	0.000672	CcSEcCtD
Epirubicin—Urinary tract disorder—Temozolomide—brain cancer	4.77e-05	0.000669	CcSEcCtD
Epirubicin—Oedema peripheral—Temozolomide—brain cancer	4.76e-05	0.000667	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.75e-05	0.00196	CbGpPWpGaD
Epirubicin—Connective tissue disorder—Temozolomide—brain cancer	4.75e-05	0.000666	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	4.74e-05	0.00195	CbGpPWpGaD
Epirubicin—Urethral disorder—Temozolomide—brain cancer	4.74e-05	0.000664	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.69e-05	0.00193	CbGpPWpGaD
Epirubicin—Feeling abnormal—Procarbazine—brain cancer	4.68e-05	0.000656	CcSEcCtD
Epirubicin—Eye disorder—Carmustine—brain cancer	4.67e-05	0.000655	CcSEcCtD
Epirubicin—Convulsion—Hydroxyurea—brain cancer	4.66e-05	0.000654	CcSEcCtD
Epirubicin—Visual impairment—Temozolomide—brain cancer	4.66e-05	0.000653	CcSEcCtD
Epirubicin—Gastrointestinal pain—Procarbazine—brain cancer	4.64e-05	0.000651	CcSEcCtD
Epirubicin—Flushing—Carmustine—brain cancer	4.64e-05	0.000651	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—brain cancer	4.62e-05	0.0019	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.62e-05	0.0019	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—brain cancer	4.61e-05	0.0019	CbGpPWpGaD
Epirubicin—Pancytopenia—Etoposide—brain cancer	4.59e-05	0.000643	CcSEcCtD
Epirubicin—Erythema multiforme—Temozolomide—brain cancer	4.57e-05	0.000641	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	4.56e-05	0.00188	CbGpPWpGaD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	4.55e-05	0.000638	CcSEcCtD
Epirubicin—Discomfort—Hydroxyurea—brain cancer	4.53e-05	0.000635	CcSEcCtD
Epirubicin—Neutropenia—Etoposide—brain cancer	4.52e-05	0.000633	CcSEcCtD
Epirubicin—Eye disorder—Temozolomide—brain cancer	4.52e-05	0.000633	CcSEcCtD
Epirubicin—Urticaria—Procarbazine—brain cancer	4.51e-05	0.000633	CcSEcCtD
Epirubicin—Tinnitus—Temozolomide—brain cancer	4.5e-05	0.000632	CcSEcCtD
Epirubicin—Abdominal pain—Procarbazine—brain cancer	4.49e-05	0.000629	CcSEcCtD
Epirubicin—Body temperature increased—Procarbazine—brain cancer	4.49e-05	0.000629	CcSEcCtD
Epirubicin—Flushing—Temozolomide—brain cancer	4.48e-05	0.000629	CcSEcCtD
Epirubicin—Cardiac disorder—Temozolomide—brain cancer	4.48e-05	0.000629	CcSEcCtD
Epirubicin—Arrhythmia—Carmustine—brain cancer	4.47e-05	0.000626	CcSEcCtD
Epirubicin—DHCR7—Metabolism—IDH1—brain cancer	4.44e-05	0.00183	CbGpPWpGaD
Epirubicin—Alopecia—Carmustine—brain cancer	4.42e-05	0.00062	CcSEcCtD
Epirubicin—Oedema—Hydroxyurea—brain cancer	4.39e-05	0.000616	CcSEcCtD
Epirubicin—Angiopathy—Temozolomide—brain cancer	4.38e-05	0.000615	CcSEcCtD
Epirubicin—Mental disorder—Carmustine—brain cancer	4.38e-05	0.000614	CcSEcCtD
Epirubicin—Infection—Hydroxyurea—brain cancer	4.37e-05	0.000612	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.36e-05	0.0018	CbGpPWpGaD
Epirubicin—Immune system disorder—Temozolomide—brain cancer	4.36e-05	0.000612	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	4.35e-05	0.00179	CbGpPWpGaD
Epirubicin—Mediastinal disorder—Temozolomide—brain cancer	4.35e-05	0.000611	CcSEcCtD
Epirubicin—Erythema—Carmustine—brain cancer	4.35e-05	0.00061	CcSEcCtD
Epirubicin—Malnutrition—Carmustine—brain cancer	4.35e-05	0.00061	CcSEcCtD
Epirubicin—Chills—Temozolomide—brain cancer	4.34e-05	0.000608	CcSEcCtD
Epirubicin—Pneumonia—Etoposide—brain cancer	4.33e-05	0.000607	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—SKP2—brain cancer	4.33e-05	0.00178	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK6—brain cancer	4.31e-05	0.00178	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—brain cancer	4.31e-05	0.00178	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—BSG—brain cancer	4.31e-05	0.00178	CbGpPWpGaD
Epirubicin—Nervous system disorder—Hydroxyurea—brain cancer	4.31e-05	0.000604	CcSEcCtD
Epirubicin—Infestation NOS—Etoposide—brain cancer	4.31e-05	0.000604	CcSEcCtD
Epirubicin—Infestation—Etoposide—brain cancer	4.31e-05	0.000604	CcSEcCtD
Epirubicin—Thrombocytopenia—Hydroxyurea—brain cancer	4.3e-05	0.000603	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCNE1—brain cancer	4.29e-05	0.00177	CbGpPWpGaD
Epirubicin—Stevens-Johnson syndrome—Etoposide—brain cancer	4.27e-05	0.000599	CcSEcCtD
Epirubicin—Alopecia—Temozolomide—brain cancer	4.27e-05	0.000599	CcSEcCtD
Epirubicin—Skin disorder—Hydroxyurea—brain cancer	4.27e-05	0.000599	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MYC—brain cancer	4.24e-05	0.00175	CbGpPWpGaD
Epirubicin—Renal failure—Etoposide—brain cancer	4.23e-05	0.000594	CcSEcCtD
Epirubicin—Mental disorder—Temozolomide—brain cancer	4.23e-05	0.000594	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	4.23e-05	0.00174	CbGpPWpGaD
Epirubicin—Neuropathy peripheral—Etoposide—brain cancer	4.22e-05	0.000592	CcSEcCtD
Epirubicin—Back pain—Carmustine—brain cancer	4.21e-05	0.00059	CcSEcCtD
Epirubicin—Erythema—Temozolomide—brain cancer	4.21e-05	0.00059	CcSEcCtD
Epirubicin—Malnutrition—Temozolomide—brain cancer	4.21e-05	0.00059	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—brain cancer	4.2e-05	0.00173	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.2e-05	0.00173	CbGpPWpGaD
Epirubicin—Stomatitis—Etoposide—brain cancer	4.2e-05	0.000589	CcSEcCtD
Epirubicin—Jaundice—Etoposide—brain cancer	4.2e-05	0.000589	CcSEcCtD
Epirubicin—Anorexia—Hydroxyurea—brain cancer	4.19e-05	0.000587	CcSEcCtD
Epirubicin—Hypersensitivity—Procarbazine—brain cancer	4.18e-05	0.000587	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.16e-05	0.00171	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.15e-05	0.00171	CbGpPWpGaD
Epirubicin—Dysgeusia—Temozolomide—brain cancer	4.12e-05	0.000578	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.12e-05	0.0017	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CG—brain cancer	4.11e-05	0.00169	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VAV1—brain cancer	4.11e-05	0.00169	CbGpPWpGaD
Epirubicin—Vision blurred—Carmustine—brain cancer	4.1e-05	0.000575	CcSEcCtD
Epirubicin—Asthenia—Procarbazine—brain cancer	4.07e-05	0.000571	CcSEcCtD
Epirubicin—Hepatobiliary disease—Etoposide—brain cancer	4.07e-05	0.000571	CcSEcCtD
Epirubicin—Back pain—Temozolomide—brain cancer	4.07e-05	0.000571	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.07e-05	0.00167	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—brain cancer	4.06e-05	0.00167	CbGpPWpGaD
Epirubicin—Anaemia—Carmustine—brain cancer	4.02e-05	0.000564	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—brain cancer	4.02e-05	0.00166	CbGpPWpGaD
Epirubicin—Agranulocytosis—Etoposide—brain cancer	4.02e-05	0.000564	CcSEcCtD
Epirubicin—Pruritus—Procarbazine—brain cancer	4.02e-05	0.000563	CcSEcCtD
Epirubicin—Agitation—Carmustine—brain cancer	4e-05	0.000561	CcSEcCtD
Epirubicin—Vision blurred—Temozolomide—brain cancer	3.96e-05	0.000556	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—BRCA2—brain cancer	3.96e-05	0.00163	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—brain cancer	3.92e-05	0.00161	CbGpPWpGaD
Epirubicin—Dyspnoea—Hydroxyurea—brain cancer	3.92e-05	0.000549	CcSEcCtD
Epirubicin—Somnolence—Hydroxyurea—brain cancer	3.91e-05	0.000548	CcSEcCtD
Epirubicin—Ill-defined disorder—Temozolomide—brain cancer	3.9e-05	0.000547	CcSEcCtD
Epirubicin—Leukopenia—Carmustine—brain cancer	3.9e-05	0.000546	CcSEcCtD
Epirubicin—Anaemia—Temozolomide—brain cancer	3.89e-05	0.000545	CcSEcCtD
Epirubicin—Diarrhoea—Procarbazine—brain cancer	3.88e-05	0.000545	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—CTNNB1—brain cancer	3.88e-05	0.0016	CbGpPWpGaD
Epirubicin—Dyspepsia—Hydroxyurea—brain cancer	3.87e-05	0.000542	CcSEcCtD
Epirubicin—Agitation—Temozolomide—brain cancer	3.87e-05	0.000542	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.86e-05	0.00159	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDK6—brain cancer	3.86e-05	0.00159	CbGpPWpGaD
Epirubicin—Hypoaesthesia—Etoposide—brain cancer	3.85e-05	0.000539	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CCNE1—brain cancer	3.83e-05	0.00158	CbGpPWpGaD
Epirubicin—Decreased appetite—Hydroxyurea—brain cancer	3.82e-05	0.000536	CcSEcCtD
Epirubicin—Urinary tract disorder—Etoposide—brain cancer	3.82e-05	0.000535	CcSEcCtD
Epirubicin—PLA2G4A—Phospholipid metabolism—PIK3CG—brain cancer	3.8e-05	0.00157	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—PCNA—brain cancer	3.8e-05	0.00156	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Hydroxyurea—brain cancer	3.79e-05	0.000532	CcSEcCtD
Epirubicin—Malaise—Temozolomide—brain cancer	3.79e-05	0.000532	CcSEcCtD
Epirubicin—Urethral disorder—Etoposide—brain cancer	3.79e-05	0.000531	CcSEcCtD
Epirubicin—Fatigue—Hydroxyurea—brain cancer	3.79e-05	0.000531	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.78e-05	0.00156	CbGpPWpGaD
Epirubicin—Vertigo—Temozolomide—brain cancer	3.78e-05	0.00053	CcSEcCtD
Epirubicin—Convulsion—Carmustine—brain cancer	3.77e-05	0.000529	CcSEcCtD
Epirubicin—Leukopenia—Temozolomide—brain cancer	3.76e-05	0.000528	CcSEcCtD
Epirubicin—Hypertension—Carmustine—brain cancer	3.76e-05	0.000527	CcSEcCtD
Epirubicin—Constipation—Hydroxyurea—brain cancer	3.76e-05	0.000527	CcSEcCtD
Epirubicin—Pain—Hydroxyurea—brain cancer	3.76e-05	0.000527	CcSEcCtD
Epirubicin—Dizziness—Procarbazine—brain cancer	3.75e-05	0.000527	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MYC—brain cancer	3.74e-05	0.00154	CbGpPWpGaD
Epirubicin—Palpitations—Temozolomide—brain cancer	3.72e-05	0.000521	CcSEcCtD
Epirubicin—Chest pain—Carmustine—brain cancer	3.71e-05	0.00052	CcSEcCtD
Epirubicin—Myalgia—Carmustine—brain cancer	3.71e-05	0.00052	CcSEcCtD
Epirubicin—Anxiety—Carmustine—brain cancer	3.69e-05	0.000518	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—brain cancer	3.69e-05	0.00152	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.69e-05	0.00152	CbGpPWpGaD
Epirubicin—Cough—Temozolomide—brain cancer	3.67e-05	0.000515	CcSEcCtD
Epirubicin—Erythema multiforme—Etoposide—brain cancer	3.66e-05	0.000513	CcSEcCtD
Epirubicin—Convulsion—Temozolomide—brain cancer	3.64e-05	0.000511	CcSEcCtD
Epirubicin—Hypertension—Temozolomide—brain cancer	3.63e-05	0.000509	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	3.63e-05	0.00149	CbGpPWpGaD
Epirubicin—Feeling abnormal—Hydroxyurea—brain cancer	3.62e-05	0.000508	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.62e-05	0.00149	CbGpPWpGaD
Epirubicin—Eye disorder—Etoposide—brain cancer	3.61e-05	0.000507	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—brain cancer	3.61e-05	0.00149	CbGpPWpGaD
Epirubicin—Vomiting—Procarbazine—brain cancer	3.61e-05	0.000506	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.6e-05	0.00148	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.59e-05	0.00148	CbGpPWpGaD
Epirubicin—Cardiac disorder—Etoposide—brain cancer	3.59e-05	0.000503	CcSEcCtD
Epirubicin—Flushing—Etoposide—brain cancer	3.59e-05	0.000503	CcSEcCtD
Epirubicin—Confusional state—Carmustine—brain cancer	3.58e-05	0.000502	CcSEcCtD
Epirubicin—Arthralgia—Temozolomide—brain cancer	3.58e-05	0.000502	CcSEcCtD
Epirubicin—Myalgia—Temozolomide—brain cancer	3.58e-05	0.000502	CcSEcCtD
Epirubicin—Rash—Procarbazine—brain cancer	3.58e-05	0.000502	CcSEcCtD
Epirubicin—Dermatitis—Procarbazine—brain cancer	3.58e-05	0.000502	CcSEcCtD
Epirubicin—Anxiety—Temozolomide—brain cancer	3.57e-05	0.0005	CcSEcCtD
Epirubicin—Headache—Procarbazine—brain cancer	3.56e-05	0.000499	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	3.56e-05	0.000499	CcSEcCtD
Epirubicin—Oedema—Carmustine—brain cancer	3.55e-05	0.000498	CcSEcCtD
Epirubicin—Discomfort—Temozolomide—brain cancer	3.54e-05	0.000496	CcSEcCtD
Epirubicin—Infection—Carmustine—brain cancer	3.53e-05	0.000495	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ENO2—brain cancer	3.51e-05	0.00145	CbGpPWpGaD
Epirubicin—Angiopathy—Etoposide—brain cancer	3.51e-05	0.000492	CcSEcCtD
Epirubicin—Dry mouth—Temozolomide—brain cancer	3.5e-05	0.000491	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	3.49e-05	0.00144	CbGpPWpGaD
Epirubicin—Immune system disorder—Etoposide—brain cancer	3.49e-05	0.00049	CcSEcCtD
Epirubicin—Mediastinal disorder—Etoposide—brain cancer	3.48e-05	0.000489	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—brain cancer	3.48e-05	0.00143	CbGpPWpGaD
Epirubicin—Thrombocytopenia—Carmustine—brain cancer	3.48e-05	0.000488	CcSEcCtD
Epirubicin—Body temperature increased—Hydroxyurea—brain cancer	3.47e-05	0.000487	CcSEcCtD
Epirubicin—Chills—Etoposide—brain cancer	3.47e-05	0.000486	CcSEcCtD
Epirubicin—Tachycardia—Carmustine—brain cancer	3.47e-05	0.000486	CcSEcCtD
Epirubicin—Confusional state—Temozolomide—brain cancer	3.46e-05	0.000485	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	3.45e-05	0.00142	CbGpPWpGaD
Epirubicin—Oedema—Temozolomide—brain cancer	3.43e-05	0.000481	CcSEcCtD
Epirubicin—Anaphylactic shock—Temozolomide—brain cancer	3.43e-05	0.000481	CcSEcCtD
Epirubicin—Alopecia—Etoposide—brain cancer	3.42e-05	0.000479	CcSEcCtD
Epirubicin—Infection—Temozolomide—brain cancer	3.41e-05	0.000478	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.4e-05	0.0014	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—PCNA—brain cancer	3.4e-05	0.0014	CbGpPWpGaD
Epirubicin—Anorexia—Carmustine—brain cancer	3.39e-05	0.000475	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	3.39e-05	0.00139	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.38e-05	0.00139	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.38e-05	0.00139	CbGpPWpGaD
Epirubicin—Nausea—Procarbazine—brain cancer	3.37e-05	0.000473	CcSEcCtD
Epirubicin—Nervous system disorder—Temozolomide—brain cancer	3.37e-05	0.000472	CcSEcCtD
Epirubicin—Thrombocytopenia—Temozolomide—brain cancer	3.36e-05	0.000471	CcSEcCtD
Epirubicin—Skin disorder—Temozolomide—brain cancer	3.33e-05	0.000468	CcSEcCtD
Epirubicin—Hypotension—Carmustine—brain cancer	3.32e-05	0.000465	CcSEcCtD
Epirubicin—Hyperhidrosis—Temozolomide—brain cancer	3.32e-05	0.000465	CcSEcCtD
Epirubicin—Dysgeusia—Etoposide—brain cancer	3.3e-05	0.000462	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDK4—brain cancer	3.28e-05	0.00135	CbGpPWpGaD
Epirubicin—Anorexia—Temozolomide—brain cancer	3.27e-05	0.000459	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PTCH2—brain cancer	3.26e-05	0.00134	CbGpPWpGaD
Epirubicin—Back pain—Etoposide—brain cancer	3.26e-05	0.000457	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCNE1—brain cancer	3.25e-05	0.00134	CbGpPWpGaD
Epirubicin—Hypersensitivity—Hydroxyurea—brain cancer	3.24e-05	0.000454	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Carmustine—brain cancer	3.24e-05	0.000454	CcSEcCtD
Epirubicin—Muscle spasms—Etoposide—brain cancer	3.24e-05	0.000454	CcSEcCtD
Epirubicin—Insomnia—Carmustine—brain cancer	3.21e-05	0.000451	CcSEcCtD
Epirubicin—Paraesthesia—Carmustine—brain cancer	3.19e-05	0.000447	CcSEcCtD
Epirubicin—Dyspnoea—Carmustine—brain cancer	3.17e-05	0.000444	CcSEcCtD
Epirubicin—Somnolence—Carmustine—brain cancer	3.16e-05	0.000443	CcSEcCtD
Epirubicin—Asthenia—Hydroxyurea—brain cancer	3.15e-05	0.000442	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Temozolomide—brain cancer	3.13e-05	0.000439	CcSEcCtD
Epirubicin—Ill-defined disorder—Etoposide—brain cancer	3.12e-05	0.000438	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.11e-05	0.00128	CbGpPWpGaD
Epirubicin—Anaemia—Etoposide—brain cancer	3.11e-05	0.000436	CcSEcCtD
Epirubicin—Insomnia—Temozolomide—brain cancer	3.1e-05	0.000435	CcSEcCtD
Epirubicin—Decreased appetite—Carmustine—brain cancer	3.09e-05	0.000433	CcSEcCtD
Epirubicin—Paraesthesia—Temozolomide—brain cancer	3.08e-05	0.000432	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Carmustine—brain cancer	3.07e-05	0.00043	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	3.06e-05	0.00126	CbGpPWpGaD
Epirubicin—Dyspnoea—Temozolomide—brain cancer	3.06e-05	0.000429	CcSEcCtD
Epirubicin—Somnolence—Temozolomide—brain cancer	3.05e-05	0.000428	CcSEcCtD
Epirubicin—Constipation—Carmustine—brain cancer	3.04e-05	0.000426	CcSEcCtD
Epirubicin—Pain—Carmustine—brain cancer	3.04e-05	0.000426	CcSEcCtD
Epirubicin—Malaise—Etoposide—brain cancer	3.03e-05	0.000426	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—SKP2—brain cancer	3.03e-05	0.00125	CbGpPWpGaD
Epirubicin—Vertigo—Etoposide—brain cancer	3.02e-05	0.000424	CcSEcCtD
Epirubicin—Dyspepsia—Temozolomide—brain cancer	3.02e-05	0.000424	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	3.02e-05	0.00124	CbGpPWpGaD
Epirubicin—Leukopenia—Etoposide—brain cancer	3.01e-05	0.000422	CcSEcCtD
Epirubicin—Diarrhoea—Hydroxyurea—brain cancer	3.01e-05	0.000422	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—BRCA2—brain cancer	3e-05	0.00124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—OR4C12—brain cancer	2.99e-05	0.00123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—OR14C36—brain cancer	2.99e-05	0.00123	CbGpPWpGaD
Epirubicin—Decreased appetite—Temozolomide—brain cancer	2.98e-05	0.000418	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Temozolomide—brain cancer	2.96e-05	0.000416	CcSEcCtD
Epirubicin—Fatigue—Temozolomide—brain cancer	2.96e-05	0.000415	CcSEcCtD
Epirubicin—Loss of consciousness—Etoposide—brain cancer	2.96e-05	0.000415	CcSEcCtD
Epirubicin—Cough—Etoposide—brain cancer	2.94e-05	0.000412	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDK4—brain cancer	2.94e-05	0.00121	CbGpPWpGaD
Epirubicin—Pain—Temozolomide—brain cancer	2.94e-05	0.000412	CcSEcCtD
Epirubicin—Constipation—Temozolomide—brain cancer	2.94e-05	0.000412	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.93e-05	0.00121	CbGpPWpGaD
Epirubicin—Feeling abnormal—Carmustine—brain cancer	2.93e-05	0.00041	CcSEcCtD
Epirubicin—Convulsion—Etoposide—brain cancer	2.92e-05	0.000409	CcSEcCtD
Epirubicin—Hypertension—Etoposide—brain cancer	2.91e-05	0.000407	CcSEcCtD
Epirubicin—Dizziness—Hydroxyurea—brain cancer	2.91e-05	0.000407	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CCNE1—brain cancer	2.91e-05	0.0012	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Carmustine—brain cancer	2.9e-05	0.000407	CcSEcCtD
Epirubicin—ABCC1—Disease—DTX2—brain cancer	2.9e-05	0.0012	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PCNA—brain cancer	2.88e-05	0.00119	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	2.87e-05	0.00118	CbGpPWpGaD
Epirubicin—Chest pain—Etoposide—brain cancer	2.87e-05	0.000402	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	2.85e-05	0.000399	CcSEcCtD
Epirubicin—Discomfort—Etoposide—brain cancer	2.83e-05	0.000397	CcSEcCtD
Epirubicin—Feeling abnormal—Temozolomide—brain cancer	2.83e-05	0.000397	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—TRPC6—brain cancer	2.83e-05	0.00116	CbGpPWpGaD
Epirubicin—Abdominal pain—Carmustine—brain cancer	2.81e-05	0.000394	CcSEcCtD
Epirubicin—Body temperature increased—Carmustine—brain cancer	2.81e-05	0.000394	CcSEcCtD
Epirubicin—Gastrointestinal pain—Temozolomide—brain cancer	2.81e-05	0.000394	CcSEcCtD
Epirubicin—Vomiting—Hydroxyurea—brain cancer	2.79e-05	0.000392	CcSEcCtD
Epirubicin—Rash—Hydroxyurea—brain cancer	2.77e-05	0.000389	CcSEcCtD
Epirubicin—Confusional state—Etoposide—brain cancer	2.77e-05	0.000388	CcSEcCtD
Epirubicin—Dermatitis—Hydroxyurea—brain cancer	2.77e-05	0.000388	CcSEcCtD
Epirubicin—Headache—Hydroxyurea—brain cancer	2.75e-05	0.000386	CcSEcCtD
Epirubicin—Anaphylactic shock—Etoposide—brain cancer	2.75e-05	0.000385	CcSEcCtD
Epirubicin—Infection—Etoposide—brain cancer	2.73e-05	0.000383	CcSEcCtD
Epirubicin—Urticaria—Temozolomide—brain cancer	2.73e-05	0.000382	CcSEcCtD
Epirubicin—Abdominal pain—Temozolomide—brain cancer	2.71e-05	0.000381	CcSEcCtD
Epirubicin—Body temperature increased—Temozolomide—brain cancer	2.71e-05	0.000381	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDK6—brain cancer	2.7e-05	0.00111	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.7e-05	0.00111	CbGpPWpGaD
Epirubicin—Thrombocytopenia—Etoposide—brain cancer	2.69e-05	0.000377	CcSEcCtD
Epirubicin—Tachycardia—Etoposide—brain cancer	2.68e-05	0.000376	CcSEcCtD
Epirubicin—Skin disorder—Etoposide—brain cancer	2.67e-05	0.000374	CcSEcCtD
Epirubicin—Hyperhidrosis—Etoposide—brain cancer	2.66e-05	0.000372	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.63e-05	0.00108	CbGpPWpGaD
Epirubicin—Anorexia—Etoposide—brain cancer	2.62e-05	0.000367	CcSEcCtD
Epirubicin—Hypersensitivity—Carmustine—brain cancer	2.62e-05	0.000367	CcSEcCtD
Epirubicin—Nausea—Hydroxyurea—brain cancer	2.61e-05	0.000366	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	2.61e-05	0.00107	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—brain cancer	2.58e-05	0.00106	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PCNA—brain cancer	2.57e-05	0.00106	CbGpPWpGaD
Epirubicin—Hypotension—Etoposide—brain cancer	2.57e-05	0.00036	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ABR—brain cancer	2.56e-05	0.00105	CbGpPWpGaD
Epirubicin—Asthenia—Carmustine—brain cancer	2.55e-05	0.000357	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—DTX2—brain cancer	2.54e-05	0.00105	CbGpPWpGaD
Epirubicin—Hypersensitivity—Temozolomide—brain cancer	2.53e-05	0.000355	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—brain cancer	2.51e-05	0.00103	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDK4—brain cancer	2.49e-05	0.00102	CbGpPWpGaD
Epirubicin—Paraesthesia—Etoposide—brain cancer	2.47e-05	0.000346	CcSEcCtD
Epirubicin—Asthenia—Temozolomide—brain cancer	2.46e-05	0.000345	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	2.46e-05	0.00101	CbGpPWpGaD
Epirubicin—Dyspnoea—Etoposide—brain cancer	2.45e-05	0.000343	CcSEcCtD
Epirubicin—Somnolence—Etoposide—brain cancer	2.44e-05	0.000342	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—brain cancer	2.44e-05	0.001	CbGpPWpGaD
Epirubicin—Diarrhoea—Carmustine—brain cancer	2.43e-05	0.000341	CcSEcCtD
Epirubicin—Pruritus—Temozolomide—brain cancer	2.43e-05	0.000341	CcSEcCtD
Epirubicin—Decreased appetite—Etoposide—brain cancer	2.39e-05	0.000335	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Etoposide—brain cancer	2.37e-05	0.000333	CcSEcCtD
Epirubicin—Fatigue—Etoposide—brain cancer	2.37e-05	0.000332	CcSEcCtD
Epirubicin—Dizziness—Carmustine—brain cancer	2.35e-05	0.000329	CcSEcCtD
Epirubicin—Pain—Etoposide—brain cancer	2.35e-05	0.000329	CcSEcCtD
Epirubicin—Constipation—Etoposide—brain cancer	2.35e-05	0.000329	CcSEcCtD
Epirubicin—Diarrhoea—Temozolomide—brain cancer	2.35e-05	0.000329	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.32e-05	0.000956	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.3e-05	0.000946	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.28e-05	0.000937	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	2.27e-05	0.000936	CbGpPWpGaD
Epirubicin—Dizziness—Temozolomide—brain cancer	2.27e-05	0.000318	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MYC—brain cancer	2.26e-05	0.000932	CbGpPWpGaD
Epirubicin—Feeling abnormal—Etoposide—brain cancer	2.26e-05	0.000317	CcSEcCtD
Epirubicin—Vomiting—Carmustine—brain cancer	2.26e-05	0.000317	CcSEcCtD
Epirubicin—Gastrointestinal pain—Etoposide—brain cancer	2.25e-05	0.000315	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDKN2A—brain cancer	2.24e-05	0.000924	CbGpPWpGaD
Epirubicin—Rash—Carmustine—brain cancer	2.24e-05	0.000314	CcSEcCtD
Epirubicin—Dermatitis—Carmustine—brain cancer	2.24e-05	0.000314	CcSEcCtD
Epirubicin—Headache—Carmustine—brain cancer	2.23e-05	0.000312	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDK4—brain cancer	2.22e-05	0.000916	CbGpPWpGaD
Epirubicin—Vomiting—Temozolomide—brain cancer	2.18e-05	0.000306	CcSEcCtD
Epirubicin—Urticaria—Etoposide—brain cancer	2.18e-05	0.000306	CcSEcCtD
Epirubicin—Body temperature increased—Etoposide—brain cancer	2.17e-05	0.000305	CcSEcCtD
Epirubicin—Abdominal pain—Etoposide—brain cancer	2.17e-05	0.000305	CcSEcCtD
Epirubicin—Rash—Temozolomide—brain cancer	2.16e-05	0.000304	CcSEcCtD
Epirubicin—Dermatitis—Temozolomide—brain cancer	2.16e-05	0.000303	CcSEcCtD
Epirubicin—Headache—Temozolomide—brain cancer	2.15e-05	0.000302	CcSEcCtD
Epirubicin—ABCC1—Disease—HES5—brain cancer	2.13e-05	0.000878	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND1—brain cancer	2.12e-05	0.000873	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VAV1—brain cancer	2.12e-05	0.000872	CbGpPWpGaD
Epirubicin—Nausea—Carmustine—brain cancer	2.11e-05	0.000296	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—BRCA2—brain cancer	2.1e-05	0.000864	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2C9—brain cancer	2.1e-05	0.000863	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2C9—brain cancer	2.06e-05	0.000846	CbGpPWpGaD
Epirubicin—Nausea—Temozolomide—brain cancer	2.04e-05	0.000286	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CCNE1—brain cancer	2.03e-05	0.000837	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.02e-05	0.000833	CbGpPWpGaD
Epirubicin—Hypersensitivity—Etoposide—brain cancer	2.02e-05	0.000284	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	2.01e-05	0.000829	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.01e-05	0.000828	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.99e-05	0.00082	CbGpPWpGaD
Epirubicin—Asthenia—Etoposide—brain cancer	1.97e-05	0.000276	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.95e-05	0.000805	CbGpPWpGaD
Epirubicin—Pruritus—Etoposide—brain cancer	1.94e-05	0.000273	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PTCH2—brain cancer	1.93e-05	0.000794	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.9e-05	0.000783	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND1—brain cancer	1.9e-05	0.00078	CbGpPWpGaD
Epirubicin—Diarrhoea—Etoposide—brain cancer	1.88e-05	0.000264	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—HES5—brain cancer	1.87e-05	0.000769	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.86e-05	0.000767	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—brain cancer	1.84e-05	0.000756	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.82e-05	0.00075	CbGpPWpGaD
Epirubicin—Dizziness—Etoposide—brain cancer	1.82e-05	0.000255	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—STRADA—brain cancer	1.81e-05	0.000747	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PCNA—brain cancer	1.8e-05	0.000741	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—BSG—brain cancer	1.78e-05	0.000734	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.75e-05	0.000722	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BSG—brain cancer	1.75e-05	0.00072	CbGpPWpGaD
Epirubicin—Vomiting—Etoposide—brain cancer	1.75e-05	0.000245	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	1.74e-05	0.000716	CbGpPWpGaD
Epirubicin—Rash—Etoposide—brain cancer	1.73e-05	0.000243	CcSEcCtD
Epirubicin—Dermatitis—Etoposide—brain cancer	1.73e-05	0.000243	CcSEcCtD
Epirubicin—Headache—Etoposide—brain cancer	1.72e-05	0.000241	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—brain cancer	1.7e-05	0.0007	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—brain cancer	1.7e-05	0.0007	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SHH—brain cancer	1.68e-05	0.000692	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000676	CbGpPWpGaD
Epirubicin—Nausea—Etoposide—brain cancer	1.63e-05	0.000229	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—TRPC6—brain cancer	1.62e-05	0.000668	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.61e-05	0.000664	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CG—brain cancer	1.61e-05	0.000663	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—brain cancer	1.61e-05	0.000662	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SMO—brain cancer	1.59e-05	0.000656	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTCH1—brain cancer	1.59e-05	0.000656	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.58e-05	0.00065	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.56e-05	0.000642	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDK4—brain cancer	1.56e-05	0.000641	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—IDH1—brain cancer	1.53e-05	0.000631	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.53e-05	0.00063	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—brain cancer	1.52e-05	0.000626	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ABR—brain cancer	1.51e-05	0.000623	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—IDH1—brain cancer	1.5e-05	0.000619	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—brain cancer	1.47e-05	0.000604	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GLI2—brain cancer	1.46e-05	0.000602	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND1—brain cancer	1.44e-05	0.000591	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IDH1—brain cancer	1.43e-05	0.00059	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BSG—brain cancer	1.4e-05	0.000575	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GLI1—brain cancer	1.37e-05	0.000566	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HEY1—brain cancer	1.36e-05	0.00056	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CG—brain cancer	1.34e-05	0.000554	CbGpPWpGaD
Epirubicin—ABCC1—Disease—DLL1—brain cancer	1.33e-05	0.000549	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.33e-05	0.000548	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.32e-05	0.000545	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SUFU—brain cancer	1.3e-05	0.000536	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—brain cancer	1.29e-05	0.000531	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GFAP—brain cancer	1.26e-05	0.000518	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—brain cancer	1.25e-05	0.000514	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.22e-05	0.000504	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—VAV1—brain cancer	1.22e-05	0.0005	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ENO2—brain cancer	1.21e-05	0.000499	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—IDH1—brain cancer	1.2e-05	0.000495	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HEY1—brain cancer	1.19e-05	0.000491	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—brain cancer	1.19e-05	0.00049	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ENO2—brain cancer	1.19e-05	0.000489	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DLL1—brain cancer	1.17e-05	0.000481	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—brain cancer	1.15e-05	0.000474	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ENO2—brain cancer	1.13e-05	0.000467	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SHH—brain cancer	1.13e-05	0.000467	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	1.12e-05	0.000463	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—brain cancer	1e-05	0.000414	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SHH—brain cancer	9.94e-06	0.000409	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.78e-06	0.000403	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TRPC6—brain cancer	9.58e-06	0.000394	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ENO2—brain cancer	9.49e-06	0.000391	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—brain cancer	9.46e-06	0.00039	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—brain cancer	9.46e-06	0.00039	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTCH1—brain cancer	9.42e-06	0.000388	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMO—brain cancer	9.42e-06	0.000388	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	9.01e-06	0.000371	CbGpPWpGaD
Epirubicin—ABCC1—Disease—VAV1—brain cancer	8.19e-06	0.000337	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—brain cancer	8.06e-06	0.000332	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—brain cancer	8.04e-06	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—brain cancer	7.72e-06	0.000318	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH2—brain cancer	7.53e-06	0.00031	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VAV1—brain cancer	7.18e-06	0.000296	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HES1—brain cancer	7.04e-06	0.00029	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFRA—brain cancer	6.71e-06	0.000276	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—brain cancer	6.62e-06	0.000273	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HES1—brain cancer	6.17e-06	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—brain cancer	6.08e-06	0.00025	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—brain cancer	5.89e-06	0.000242	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFRA—brain cancer	5.88e-06	0.000242	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—brain cancer	5.71e-06	0.000235	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—brain cancer	5.56e-06	0.000229	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—brain cancer	5.45e-06	0.000224	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—brain cancer	5.43e-06	0.000224	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—brain cancer	5.2e-06	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—brain cancer	5.16e-06	0.000212	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—brain cancer	4.56e-06	0.000188	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—brain cancer	4.56e-06	0.000188	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—brain cancer	4.36e-06	0.000179	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—brain cancer	4.15e-06	0.000171	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—brain cancer	4.04e-06	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RELA—brain cancer	3.56e-06	0.000147	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—brain cancer	3.54e-06	0.000146	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—brain cancer	3.53e-06	0.000145	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—brain cancer	3.21e-06	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—brain cancer	3.13e-06	0.000129	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—brain cancer	3.1e-06	0.000127	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—brain cancer	3.08e-06	0.000127	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—brain cancer	2.86e-06	0.000118	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—brain cancer	2.8e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—brain cancer	2.73e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—brain cancer	2.7e-06	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—brain cancer	2.51e-06	0.000103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—brain cancer	2.45e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—brain cancer	2.06e-06	8.48e-05	CbGpPWpGaD
